Catalog Number UNK SUPERA |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Myocardial Infarction (1969); Renal Failure (2041); Perforation of Vessels (2135); Stenosis (2263); Obstruction/Occlusion (2422); Respiratory Failure (2484); Vascular Dissection (3160); Embolism/Embolus (4438); Thrombosis/Thrombus (4440); Unspecified Tissue Injury (4559)
|
Event Date 12/01/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
B3: date of procedure is estimated d4: the udi is unknown due to the part/lot number was not provided.D6: date of implant is estimated the device was not returned for evaluation.A review of the lot history record of the reported lot could not be conducted because the part and lot number was not provided.The reported patient effects of embolization, myocardial infarction, renal failure, restenosis, thrombosis, occlusion, vessel dissection, vessel perforation and surgical intervention are listed in the supera peripheral stent system instructions for use as potential adverse events.A conclusive cause for the reported respiratory failure, renal failure, stenosis, embolism / embolus, vascular dissection, perforation of vessels, obstruction/ occlusion, thrombosis/ thrombus, myocardial infarction, unspecified tissue injury and the relationship to the product, if any, cannot be determined.The treatments appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.The additional patient effect of death referenced in b5 is captured under separate medwatch report.As multiple devices were captured in the pmcf report, additional reports were filed under manufacturing reference numbers (b)(4).Pmcf attachment rpt2131801 rev c titled: post-market clinical follow-up evaluation report peripheral self-expanding stentsna.
|
|
Event Description
|
It was reported through the pmcf report, that the supera stent may be related to the adverse patient effects of death, myocardial infarction, pulmonary complications, renal complications, access site complications, thrombosis, embolization, dissection, perforation, occlusion, re-stenosis, revascularization, unplanned amputation / surgical intervention and re-hospitalization.Details are listed in the attached report, titled post-market clinical follow-up evaluation report peripheral self-expanding stents please see the attached post market clinical follow up evaluation report for specific information.
|
|
Search Alerts/Recalls
|
|